Jump to ContentJump to Main Navigation

Open Medicine

formerly Central European Journal of Medicine

1 Issue per year

IMPACT FACTOR 2014: 0.153
5-year IMPACT FACTOR: 0.183

SCImago Journal Rank (SJR) 2014: 0.135
Source Normalized Impact per Paper (SNIP) 2014: 0.124
Impact per Publication (IPP) 2014: 0.193

Open Access


Common variants of the mineralocorticoid and glucocorticoid receptor genes may contribute to pregnancy-related anxiety: a pilot study

1Department of Developmental Psychology, Institute of Psychology, Russian Academy of Science, Yaroslavskaya Ulitsa 13, 129366, Moscow, Russia

2Department of Molecular Diagnostics, National Research Center GosNIIgenetika, 1st Dorozhny Proezd 1, 117545, Moscow, Russia

© 2012 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. (CC BY-NC-ND 3.0)

Citation Information: Open Medicine. Volume 8, Issue 1, Pages 117–124, ISSN (Online) 2391-5463, DOI: 10.2478/s11536-012-0101-1, December 2012

Publication History

Published Online:


The hypothalamic-pituitary-adrenal (HPA) axis overactivity is thought to contribute to increased vulnerability to maternal stress. We hypothesize that functionally relevant polymorphic variants of the glucocorticoid (NR3C1) and mineralocorticoid (NR3C2) receptor genes mediating biological effects of cortisol, a major stress hormone, could also modulate the capacity to cope with pregnancy-related anxiety. Genomic DNA from the blood of 42 women with pregnancy-related anxiety and 42 age-matched women with normal pregnancy (5–6th months of gestation) were genotyped for markers rs6195 and rs10482605 of NR3C1 and two NR3C2 polymorphisms (rs5522 and rs2070951) using a Taqman allele discrimination assay. Serum total cortisol was measured using an ELISA technique. The allele Ser363 of rs6195 (the N363S polymorphism of NR3C1) was found to be associated with a higher risk of maternal stress (odds ratio (OR)=5.27; P=0.001). For NR3C2, the allele Val180 of rs5522 (I180V) also showed association with increased risk of neonatal stress (OR=1.97; P=0.038). Both predisposing gene variants were also associated with significantly elevated levels of cortisol in normally pregnant women and females with pregnancy-related anxiety. Our results suggest that pregnancy-related anxiety can be modulated by variants of NR3C1 and NR3C2 associated with increased basal cortisol levels. Thus, our findings provide evidence in support of the suggestion that elevated cortisol levels and HPA axis hyperactivity are implicated in pregnancy-related anxiety.

Keywords: Pregnancy-related anxiety; HPA axis; Cortisol; Mineralocorticoid receptor; Glucocorticoid receptor; Polymorphism

  • [1] Austin MP, Leader L. Maternal stress and obstetric and infant outcomes: epidemiological findings and neuroendocrine mechanisms. Aust N Z J Obstet Gynaecol 2000, 40, 331–337 http://dx.doi.org/10.1111/j.1479-828X.2000.tb03344.x [CrossRef]

  • [2] Low LA, Schweinhardt P. Early life adversity as a risk factor for fibromyalgia in later life. Pain Res Treat 2012, 2012:140832

  • [3] Gungor I, Oskay U, Beji NK. Biopsychosocial risk factors for preterm birth and postpartum emotional well-being: a case-control study on Turkish women without chronic illnesses. J Clin Nurs 2011, 20, 653–665 http://dx.doi.org/10.1111/j.1365-2702.2010.03532.x [CrossRef] [Web of Science]

  • [4] Vettore MV, Gama SG, Lamarca Gde A, Schilithz AO, Leal Mdo C. Housing conditions as a social determinant of low birthweight and preterm low birthweight. Rev Saude Publica 2010, 44, 1021–1031 http://dx.doi.org/10.1590/S0034-89102010005000045 [Web of Science] [CrossRef]

  • [5] Precht DH, Andersen PK, Olsen J. Severe life events and impaired fetal growth: a nation-wide study with complete follow-up. Acta Obstet Gynecol Scand 2007, 86, 266–275 http://dx.doi.org/10.1080/00016340601088406 [CrossRef] [Web of Science]

  • [6] Precht DH, Andersen PK, Olsen J. Severe life events and impaired fetal growth: a nation-wide study with complete follow-up. Acta Obstet Gynecol Scand 2007, 86, 266–275 http://dx.doi.org/10.1080/00016340601088406 [CrossRef] [Web of Science]

  • [7] Henriksen TB, Hedegaard M, Secher NJ, Wilcox AJ. Standing at work and preterm delivery. Br J Obstet Gynaecol 1995, 102, 198–206 http://dx.doi.org/10.1111/j.1471-0528.1995.tb09094.x [CrossRef]

  • [8] Hedegaard M, Henriksen TB, Sabroe S, Secher NJ. The relationship between psychological distress during pregnancy and birth weight for gestational age. Acta Obstet Gynecol Scand 1996, 75, 32–39 http://dx.doi.org/10.3109/00016349609033280 [CrossRef]

  • [9] Maina G, Saracco P, Giolito MR, Danelon D, Bogetto F, Todros T. Impact of maternal psychological distress on fetal weight, prematurity and intrauterine growth retardation. J Affect Disord 2008, 111, 214–220 http://dx.doi.org/10.1016/j.jad.2008.02.017 [Web of Science] [CrossRef]

  • [10] McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med 1995, 1, 460–463 http://dx.doi.org/10.1038/nm0595-460 [CrossRef]

  • [11] Majzoub JA, McGregor JA, Lockwood CJ, Lockwood CJ, Smith R, Taggart MS, et al. A central theory of preterm and term labor: putative role for corticotropin-releasing hormone. Am J Obstet Gynecol 1999, 180, S232–S241 http://dx.doi.org/10.1016/S0002-9378(99)70707-6 [CrossRef]

  • [12] Wadhwa PD, Porto M, Garite TJ, Chicz-DeMet A, Sandman CA. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Am J Obstet Gynecol 1998, 179, 1079–1085 http://dx.doi.org/10.1016/S0002-9378(98)70219-4 [CrossRef]

  • [13] Hobel CJ, Dunkel-Schetter C, Roesch SC, Castro LC, Arora CP. Maternal plasma corticotropinreleasing hormone associated with stress at 20 weeks’ gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol 1999,180, S257–S263 http://dx.doi.org/10.1016/S0002-9378(99)70712-X [CrossRef]

  • [14] McLean M. Bisits A. Davies J, Walters W, Hackshaw A, De Voss K, Smith R. Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and a-fetoprotein concentrations. Am J Obstet Gynecol 1999, 181, 207–215 http://dx.doi.org/10.1016/S0002-9378(99)70461-8 [CrossRef]

  • [15] Class QA, Lichtenstein P, Långström N, D’Onofrio BM. Timing of prenatal maternal exposure to severe life events and adverse pregnancy outcomes: a population study of 2.6 million pregnancies. Psychosom Med 2011, 73, 234–241 http://dx.doi.org/10.1097/PSY.0b013e31820a62ce

  • [16] Mancuso RA, Schetter CD, Rini CM, Roesch SC, Hobel CJ. Maternal prenatal anxiety and corticotropin-releasing hormone associated with timing of delivery. Psychosom Med 2004, 66, 762–769 http://dx.doi.org/10.1097/01.psy.0000138284.70670.d5 [CrossRef]

  • [17] Clark C, Ryan L, Kawachi I, Canner MJ, Berkman L, Wright RJ. Witnessing community violence in residential neighborhoods: A mental health hazard for urban women. J Urban Health 2008, 85, 22–38 http://dx.doi.org/10.1007/s11524-007-9229-8 [CrossRef] [Web of Science]

  • [18] Lindsay JR, Nieman LK. The hypothalamic-pituitaryadrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 2005, 26, 775–799 http://dx.doi.org/10.1210/er.2004-0025 [CrossRef]

  • [19] Derijk RH. Single nucleotide polymorphisms related to HPA axis reactivity. Neuroimmunomodulation 2009, 16, 340–352 http://dx.doi.org/10.1159/000216192 [CrossRef] [Web of Science]

  • [20] Mormede P, Foury A, Barat P, Corcuff JB, Terenina E, Marissal-Arvy N, et al. Molecular genetics of hypothalamic-pituitary-adrenal axis activity and function. Ann N Y Acad Sci 2011, 1220, 127–136 http://dx.doi.org/10.1111/j.1749-6632.2010.05902.x [CrossRef]

  • [21] Lanfumey L, Mongeau R, Cohen-Salmon C, Hamon M. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev 2008, 32, 1174–1184 http://dx.doi.org/10.1016/j.neubiorev.2008.04.006 [Web of Science] [CrossRef]

  • [22] Craig IW. The importance of stress and genetic variation in human aggression. Bioessays 2007, 29, 227–236 http://dx.doi.org/10.1002/bies.20538 [CrossRef] [Web of Science]

  • [23] Porter RJ, Gallagher P, Watson S, Young AH. Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berl) 2004, 173, 1–17 http://dx.doi.org/10.1007/s00213-004-1774-1 [CrossRef]

  • [24] Neumann ID, Veenema AH, Beiderbeck DI. Aggression and anxiety: social context and neurobiological links. Front Behav Neurosci 2010, 4:12 [Web of Science] [CrossRef]

  • [25] Lippman ME, Halterman RH, Leventhal BG, Perry S, Thompson EB. Glucocorticoid-binding proteins in human acute lymphoblastic leukemic blast cells. J Clin Invest 1973, 52, 1715–1725 http://dx.doi.org/10.1172/JCI107353 [CrossRef]

  • [26] Roesch SC, Dunkel-Schetter C, Woo G, Hobel CJ. Modeling the types and timing of stress in pregnancy. J Anx Str Cop 2004, 17, 87–102 http://dx.doi.org/10.1080/1061580031000123667 [CrossRef]

  • [27] Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983, 24, 386–396 http://dx.doi.org/10.2307/2136404 [CrossRef]

  • [28] Spielberger CD. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA, 1983

  • [29] Lobel M, Dunkel-Schetter C, Scrimshaw SCM. Prenatal maternal stress and prematurity: a prospective study of socioeconomically disadvantaged women. Health Psychol 1992, 11, 32–40 http://dx.doi.org/10.1037/0278-6133.11.1.32 [CrossRef]

  • [30] Klok MD, Vreeburg SA, Penninx BW, Zitman FG, de Kloet ER, DeRijk RH. Common functional mineralocorticoid receptor polymorphisms modulate the cortisol awakening response: Interaction with SSRIs. Psychoneuroendocrinology 2011, 36, 484–494 http://dx.doi.org/10.1016/j.psyneuen.2010.07.024 [Web of Science] [CrossRef]

  • [31] Geelhoed MJ, Steegers EA, Koper JW, van Rossum EF, Moll HA, Raat H, et al. Glucocorticoid receptor gene polymorphisms do not affect growth in fetal and early postnatal life. The Generation R Study. BMC Med Genet, 2010, 11:39 http://dx.doi.org/10.1186/1471-2350-11-39 [Web of Science] [CrossRef]

  • [32] Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ 2000, 320, 1468 http://dx.doi.org/10.1136/bmj.320.7247.1468 [CrossRef]

  • [33] Zhao JH. 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Bioinformatics 2004, 20, 1325–1326 http://dx.doi.org/10.1093/bioinformatics/bth071

  • [34] Derijk RH, de Kloet ER. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur J Pharmacol 2008, 583, 303–311 http://dx.doi.org/10.1016/j.ejphar.2007.11.072 [Web of Science] [CrossRef]

  • [35] van Leeuwen N, Kumsta R, Entringer S, de Kloet ER, Zitman FG, DeRijk RH, et al. Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology 2010, 35, 339–349 http://dx.doi.org/10.1016/j.psyneuen.2009.07.006 [Web of Science] [CrossRef]

  • [36] Muhtz C, Zyriax BC, Bondy B, Windler E, Otte C. Association of a common mineralocorticoid receptor gene polymorphism with salivary cortisol in healthy adults. Psychoneuroendocrinology 2011, 36, 298–301 http://dx.doi.org/10.1016/j.psyneuen.2010.08.003 [Web of Science] [CrossRef]

  • [37] van Leeuwen N, Bellingrath S, de Kloet ER, Zitman FG, DeRijk RH, Kudielka BM, Wüst S. Human mineralocorticoid receptor (MR) gene haplotypes modulate MR expression and transactivation: implication for the stress response. Psychoneuroendocrinology 2011, 36, 699–709 http://dx.doi.org/10.1016/j.psyneuen.2010.10.003 [CrossRef] [Web of Science]

  • [38] DeRijk RH, Wüst S, Meijer OC, Zennaro MC, Federenko IS, Hellhammer DH, et al. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocrinol Metab 2006, 91, 5083–5089 http://dx.doi.org/10.1210/jc.2006-0915 [CrossRef]

  • [39] Bogdan R, Perlis RH, Fagerness J, Pizzagalli DA. The impact of mineralocorticoid receptor ISO/VAL genotype (rs5522) and stress on reward learning. Genes Brain Behav 2010, 9, 658–667 [Web of Science]

  • [40] Kumsta R, Moser D, Streit F, Koper JW, Meyer J, Wüst S. Characterization of a glucocorticoid receptor gene (GR, NR3C1) promoter polymorphism reveals functionality and extends a haplotype with putative clinical relevance. Am J Med Genet B Neuropsychiatr Genet 2009, 150B, 476–482 http://dx.doi.org/10.1002/ajmg.b.30837 [Web of Science] [CrossRef]

  • [41] Gaitan D, DeBold CR, Turney MK, Zhou P, Orth DN, Kovacs WJ. Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. Mol Endocrinol 1995, 9, 1193–1201 http://dx.doi.org/10.1210/me.9.9.1193 [CrossRef]

  • [42] Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998, 83, 144–151 http://dx.doi.org/10.1210/jc.83.1.144 [CrossRef]

  • [43] Russcher H, Smit P, van den Akker EL, van Rossum EF, Brinkmann AO, de Jong FH, et al. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J Clin Endocrinol Metab 2005, 90, 5804–5810 http://dx.doi.org/10.1210/jc.2005-0646 [CrossRef]

  • [44] Wüst S, Van Rossum EF, Federenko IS, Koper JW, Kumsta R, Hellhammer DH. Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endocrinol Metab 2004, 89, 565–573 http://dx.doi.org/10.1210/jc.2003-031148 [CrossRef]

  • [45] DeRijk R, de Kloet ER. Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine 2005, 28, 263–270 http://dx.doi.org/10.1385/ENDO:28:3:263 [CrossRef]

  • [46] Kumsta R, Entringer S, Koper JW, van Rossum EF, Hellhammer DH, Wüst S. Sex- specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress. Biol Psychiatry 2007, 62, 863–899 http://dx.doi.org/10.1016/j.biopsych.2007.04.013 [Web of Science] [CrossRef]

  • [47] Crider KS, Whitehead N, Buus RM. Genetic variation associated with preterm birth: a HuGE review. Genet Med 2005, 7, 593–604 http://dx.doi.org/10.1097/01.gim.0000187223.69947.db [CrossRef]

  • [48] Spivak IM, Smirnova TIu, Gruzdev NV, Shneĭder OV, Abramchenko VV, Spivak DL. Possible correlation of polymorphism of angiotensin-converting enzyme gene with psychological aspects of birth stress. Tsitologiia 2006, 48, 875–882 (in Russian) [PubMed]

  • [49] Spivak IM, Seĭlieva NA, Smirnova TIu, Bolotskikh VM, Abramchenko VV, Spivak DL. Polymorphisms of genes of rennin-angiotensin system and their correlation with psychological manifestations of birth stress. Tsitologiia 2008, 50, 899–906 (in Russian)

  • [50] El Hage W, Powell JF, Surguladze SA. Vulnerability to depression: what is the role of stress genes in gene x environment interaction? Psychol Med 2009, 39, 1407–1411 http://dx.doi.org/10.1017/S0033291709005236 [CrossRef] [Web of Science]

Comments (0)

Please log in or register to comment.